103 related articles for article (PubMed ID: 6283276)
1. Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis.
Tait GA; Booker PD; Wilson GJ; Coles JG; Steward DJ; MacGregor DC
J Thorac Cardiovasc Surg; 1982 Jun; 83(6):824-9. PubMed ID: 6283276
[TBL] [Abstract][Full Text] [Related]
2. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
[TBL] [Abstract][Full Text] [Related]
3. The relative importance of alkalinity, temperature, and the washout effect of bicarbonate-buffered, multidose cardioplegic solution.
Lange R; Cavanaugh AC; Zierler M; Marston W; Kloner RA; Khuri SF
Circulation; 1984 Sep; 70(3 Pt 2):I75-83. PubMed ID: 6430594
[TBL] [Abstract][Full Text] [Related]
4. European versus North American cardioplegia: comparison of Bretschneider's and Roe's cardioplegic solutions in a canine model of cardiopulmonary bypass.
Wilson GJ; Axford-Gatley RA; Bush BG; Romaschin AD; Mickle DA
Thorac Cardiovasc Surg; 1990 Feb; 38(1):10-4. PubMed ID: 2106734
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myocardial temperatures with multidose cardioplegia versus single-dose cardioplegia and myocardial surface cooling during coronary artery bypass grafting.
Daily PO; Jones B; Folkerth TL; Dembitsky WP; Moores WY; Reichman RT
J Thorac Cardiovasc Surg; 1989 May; 97(5):715-24. PubMed ID: 2785234
[TBL] [Abstract][Full Text] [Related]
7. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
8. Calcium paradox in an in vivo model of multidose cardioplegia and moderate hypothermia. Prevention with diltiazem or trace calcium levels.
Rebeyka IM; Axford-Gatley RA; Bush BG; del Nido PJ; Mickle DA; Romaschin AD; Wilson GJ
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):475-83. PubMed ID: 2308365
[TBL] [Abstract][Full Text] [Related]
9. Imidazole-buffered cardioplegic solution. Improved myocardial preservation during global ischemia.
Vander Woude JC; Christlieb IY; Sicard GA; Clark RE
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):225-34. PubMed ID: 4021525
[TBL] [Abstract][Full Text] [Related]
10. [Buffering capacity of histidine in cardioplegia analyzed by myocardial production of lactate and alanine].
Ohkado A; Cao-Danh H; Sommers KE; del Nido PJ
Kyobu Geka; 1993 Nov; 46(12):1021-4. PubMed ID: 8230926
[TBL] [Abstract][Full Text] [Related]
11. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
12. Effect of increasing volume of cardioplegic solution on postischemic myocardial recovery.
Saydjari R; Asimakis G; Conti VR
J Thorac Cardiovasc Surg; 1987 Aug; 94(2):234-40. PubMed ID: 3613622
[TBL] [Abstract][Full Text] [Related]
13. Reduction in myocardial acidosis using blood cardioplegia.
Warner KG; Josa M; Marston W; Butler MD; Gherardi PC; Assousa SN; Cavanaugh AC; Hunt H; Khuri SF
J Surg Res; 1987 Mar; 42(3):247-56. PubMed ID: 3821087
[TBL] [Abstract][Full Text] [Related]
14. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment.
del Nido PJ; Wilson GJ; Mickle DA; Bush BG; Rebeyka IM; Klement P; Harding R; Tait GA
J Thorac Cardiovasc Surg; 1985 May; 89(5):689-99. PubMed ID: 3990319
[TBL] [Abstract][Full Text] [Related]
15. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
[TBL] [Abstract][Full Text] [Related]
16. Cardioplegic infusion: the safe limits of pressure and temperature.
Johnson RE; Dorsey LM; Moye SJ; Hatcher CR; Guyton RA
J Thorac Cardiovasc Surg; 1982 Jun; 83(6):813-24. PubMed ID: 7087508
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
Catinella FP; Cunningham JN; Spencer FC
J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide attenuates cardiomyocytic apoptosis via diminished mitochondrial complex I up-regulation from cardiac ischemia-reperfusion injury under cardiopulmonary bypass.
Yeh CH; Lin YM; Wu YC; Wang YC; Lin PJ
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):180-8. PubMed ID: 15282453
[TBL] [Abstract][Full Text] [Related]
19. The potential hazard of particulate contamination of cardioplegic solutions.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypercarbic acidotic reperfusion on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
Nomura F; Aoki M; Forbess JM; Mayer JE
Circulation; 1994 Nov; 90(5 Pt 2):II321-7. PubMed ID: 7955274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
